Abstract:CD73 catalyzes the conversion of extracellular nucleosides to adenosine, modulating inflammatory and T cell responses. Elevated expression of CD73 marks subpopulations of murine memory B cells (MBC), but its role in memory development or function is unknown. Here, we demonstrate that CD73 is progressively upregulated on germinal center (GC) B cells following immunization, is expressed at even higher levels among T follicular helper cells, but is absent among plasma cells (PC) and plasmablasts (PB). We analyzed… Show more
“…It seems likely, then, that IgM memory cells are regulated via adenosine receptors, which likely function by regulating inflammation, as has been reported for CD73. However, our initial studies of CD73-deficient mice have failed to reveal a requirement for this receptor for the generation or function of IgM memory cells (unpublished data), findings which are consistent with other published studies that have reported relatively modest effects of CD73-deficiency in B cells [75]. Nevertheless, further investigation into a role for adenosine and related receptors on memory B cells will likely be informative.…”
CD11c+ T-bet+ B cells have now been detected and characterized in different experimental and clinical settings, in both mice and humans. Whether such cells are monolithic, or define subsets of B cells with different functions is not yet known. Our studies have identified CD11c+ IgM+ CD19hi splenic IgM memory B cells that appear at approximately three weeks post-ehrlichial infection, and persist indefinitely, during low-level chronic ehrlichial infection. Although the CD11c+T-bet+ B cells we have described are distinct, they appear to share many features with similar cells detected under diverse conditions, including viral infections, aging, and autoimmunity. We propose that CD11c+ T-bet+ B cells as a group share characteristics of memory B cells that are maintained under conditions of inflammation and/or low-level chronic antigen stimulation. In some cases, these cells may be advantageous, by providing immunity to re-infection, but in others may be deleterious, by contributing to aged-associated autoimmune responses.
“…It seems likely, then, that IgM memory cells are regulated via adenosine receptors, which likely function by regulating inflammation, as has been reported for CD73. However, our initial studies of CD73-deficient mice have failed to reveal a requirement for this receptor for the generation or function of IgM memory cells (unpublished data), findings which are consistent with other published studies that have reported relatively modest effects of CD73-deficiency in B cells [75]. Nevertheless, further investigation into a role for adenosine and related receptors on memory B cells will likely be informative.…”
CD11c+ T-bet+ B cells have now been detected and characterized in different experimental and clinical settings, in both mice and humans. Whether such cells are monolithic, or define subsets of B cells with different functions is not yet known. Our studies have identified CD11c+ IgM+ CD19hi splenic IgM memory B cells that appear at approximately three weeks post-ehrlichial infection, and persist indefinitely, during low-level chronic ehrlichial infection. Although the CD11c+T-bet+ B cells we have described are distinct, they appear to share many features with similar cells detected under diverse conditions, including viral infections, aging, and autoimmunity. We propose that CD11c+ T-bet+ B cells as a group share characteristics of memory B cells that are maintained under conditions of inflammation and/or low-level chronic antigen stimulation. In some cases, these cells may be advantageous, by providing immunity to re-infection, but in others may be deleterious, by contributing to aged-associated autoimmune responses.
“…Consistent with a role for CD73 in CSR, B cells from CVI patients show very low CD73 expression, and CD73 on neonate B cells gradually increases during the first 6 months of life, correlating with their ability to make IgG. In vivo immunization of CD73âdeficient mice, however, revealed only slightly delayed or normal isotype switched responses …”
Summary
Cancers are able to grow by subverting immune suppressive pathways, to prevent the malignant cells as being recognized as dangerous or foreign. This mechanism prevents the cancer from being eliminated by the immune system and allows disease to progress from a very early stage to a lethal state. Immunotherapies are newly developing interventions that modify the patientâs immune system to fight cancer, by either directly stimulating rejection-type processes or by blocking suppressive pathways. Extracellular adenosine generated by the ectonucleotidases CD39 and CD73 is a newly recognized âimmune checkpoint mediatorâ that interferes with anti-tumor immune responses. In this review, we focus on CD39 and CD73 ectoenzymes and encompass aspects of the biochemistry of these molecules as well as detailing the distribution and function on immune cells. Effects of CD39 and CD73 inhibition in preclinical and clinical studies are discussed. Finally, we provide insights into potential clinical application of adenosinergic and other purinergic-targeting therapies and forecast how these might develop in combination with other anti-cancer modalities.
“…Studies with CD80-deficient mice have showed that CD80 plays an important role in regulating interactions between B and T cells during early and late GC formation and lack of CD80 expression leads to an impaired development of long lived plasma cells (Good-Jacobson et al, 2012). Expression of CD73 is also upregulated in highly functional MBCs and its deletion prevented the development of LLPCs in the bone marrow (Conter et al, 2014). To determine whether blood stage infection perturbed the expression of CD80 and CD73, mice were infected with parasites as described above and CSP-specific B cells were analyzed for surface expression of these phenotypic markers 30 days later.…”
Summary
Many current malaria vaccines target the pre-erythrocytic stage of infection in the liver. However, in malaria endemic regions, increased blood stage exposure is associated with decreased vaccine efficacy, thereby challenging current vaccine efforts. We hypothesized that pre-erythrocytic humoral immunity is directly disrupted by blood stage infection. To investigate this possibility, we used Plasmodium-antigen tetramers to analyze B cells after infection with either late-liver stage arresting parasites or wild type parasites that progress to the blood stage. Our data demonstrate that IgG antibodies against the pre-erythrocytic antigen, circumsporozoite protein (CSP), are generated only in response to the attenuated, but not the wild-type infection. Further analyses revealed that blood stage malaria inhibits CSP-specific germinal center B cell differentiation and modulates chemokine expression. This results in aberrant memory formation and the loss of a rapid secondary B cell response. These data highlight how immunization with attenuated parasites may drive optimal immunity to malaria.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.